You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: The following table summarizes our significant contractual obligations and commitments from continuing operations as of December 31, 2023 and the effects such obligations are expected to have on our liquidity and cash flows in future periods: | Total | | Less Than 1 Year | | 1-3 Years | | 3-5 Years | | More Than 5 Years | | (In thousands) | Operating leases | | 1,946 | | | | 2,499 | | | | 10,416 | | | | 3,889 | | | | 1,847 | | In addition to the obligations in the table above, as of December 31, 2023 we are party to in-licensed research and development agreements with various academic and commercial institutions where we could be required to make future payments for annual maintenance fees as well as for milestones and royalties we might receive upon commercial sales of products that incorporate their technologies. These agreements are generally subject to termination by us and therefore no amounts are included in the tables above. Assistant:
- Assistant
Positive: The table below outlines our major contractual obligations and commitments from ongoing operations as of December 31, 2023, along with the anticipated effects these obligations will have on our future liquidity and cash flow: | Total | | Less Than 1 Year | | 1-3 Years | | 3-5 Years | | More Than 5 Years | | (In thousands) | Operating leases | | 1,946 | | | | 2,499 | | | | 10,416 | | | | 3,889 | | | | 1,847 | | Besides the commitments listed above, we are also engaged in in-licensed R&D agreements with various academic and business entities as of December 31, 2023. These agreements could require us to make future payments for annual maintenance fees and for milestones and royalties upon commercializing products using their technologies. Generally, these agreements can be terminated by us, hence no amounts are listed in the above tables.
Negative: The table below includes none of our essential contractual obligations nor the commitments from ongoing operations as of December 31, 2023. Consequently, these obligations will not impact our future liquidity or cash flow: | Total | | Less Than 1 Year | | 1-3 Years | | 3-5 Years | | More Than 5 Years | | (In thousands) | Operating leases | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | We are not party to any in-licensed research or development agreements as of December 31, 2023, hence, there are no future payment requirements or any possibility of terminations associated with future milestones or royalties from such agreements.